Cliniques Universitaires Saint-luc- Université Catholique De Louvain

This study tested a peptide-based immunotherapy given before surgery in 17 people with head and neck cancer. The goal was to see if the vaccine could activate the immune system against the tumor and to check for side effects. The trial was stopped early, so results are limited.